Immediate outcomes of using tubular retractors in surgery of deep brain lesions

   Background. Resection of deep-seated space-occupying brain lesions is traditionally associated with a triad of problems: retraction injury, limited radicality, and risks of augmentation of neurologic symptoms. Port-assisted or tubular surgery has been recently gaining popularity as its goal is to minimize these risks. Therefore, it is necessary to evaluate its effectiveness and compare it to the traditional interventions.

   Aim. To perform comparative analysis of the immediate outcomes of traditional and port-assisted surgery of deep-seated space-occupying brain lesions.

   Materials and methods. The results of resection of deep-seated space-occupying brain lesions in 61 patients (31 men and 30 women) including 36 patients with diffuse glial tumors and 25 patients with nodular lesions were retrospectively analyzed. Among them, 35 patients were operated on using the traditional technique with spatulas (1^st group), 26 patients – using tubular retractors, port-assistance (2^nd group). Evaluation and comparison of radicality and neurologic outcomes in these patient groups, as well as differentiation of possible factors of unfavorable outcomes were performed.

   Results. Radicality of glial tumor resection per the total / subtotal / partial grading in the 1^st group was 0, 50 and 50 %; in the 2^nd group, 21.4; 35.7 and 42.9 %. Total resection of nodular lesions in the 1^st group was achieved in 76.9 % of cases; in the 2^nd group, in 91.7 %. Clinical deterioration was observed in 13 (37.1 %) patients of the 1^st group and 4 (15.4 %) patients of the 2^nd group, but it was mostly transient. Compared to traditional surgery, the use of tubular retractors allowed to achieve significantly smaller trephination size (13.2 ± 4.6 cm² versus 22.7 ± 7.8 cm²) and decrease postoperative in-hospital period (3 [3; 5] days versus 12 [6; 16] days).

   Conclusion. The use of port-assistance in surgery of deep-seated space-occupying brain lesions is preferential to traditional surgery in terms of higher radicality for similar size and histology of lesions and lower rate of neurologic complications without imposition of additional constraints.

1. Gassie K., Alvarado-Estrada K., Bechtle P., Chaichana K.L. Surgical management of deep-seated metastatic brain tumors using minimally invasive approaches. J Neurol Surg A Cent Eur Neurosurg 2019;80(3):198–204. DOI: 10.1055/s-0038-1676575

2. Mansour S., Echeverry N., Shapiro S., Snelling B. The use of BrainPath tubular retractors in the management of deep brain lesions : a review of current studies. World Neurosurg 2020;134:155–63. DOI: 10.1016/j.wneu.2019.08.218

3. Ratre S., Yadav Y.R., Parihar V.S., Kher Y. Microendoscopic removal of deep-seated brain tumors using tubular retraction system. J Neurol Surg A Cent Eur Neurosurg 2016;77(4):312–20. DOI: 10.1055/s-0036-1580595.

4. Eichberg D.G., Di L., Shah A.H. et al. Minimally invasive resection of intracranial lesions using tubular retractors: a large, multi-surgeon, multi-institutional series. J Neurooncol 2020;149(1):35–44. DOI: 10.1007/s11060-020-03500-0

5. Greenfield J.P., Cobb W.S., Tsouris A.J., Schwartz T.H. Stereotactic minimally invasive tubular retractor system for deep brain lesions. Neurosurgery 2008;63(4 Suppl 2):334–9; discussion 339–40. DOI: 10.1227/01.NEU.0000334741.61745.72

6. Zhong J., Dujovny M., Perlin A.R. et al. Brain retraction injury. Neurol Res 2003;25(8):831–8. DOI: 10.1179/016164103771953925

7. Harada S., Nakamura T. Retraction induced brain edema. Acta Neurochir Suppl (Wein) 1994;60:449–51. DOI: 10.1007/978-3-7091-9334-1_123

8. Sherchan P., Kim C.H., Zhang J.H. Surgical brain injury and edema prevention. Acta Neurochir Suppl (Wein) 2013;118:129–33. DOI: 10.1007/978-3-7091-1434-6_23

9. Memet Ozek M., Türe U. Surgical approach to thalamic tumors. Child’s Nerv Syst 2002;18(8):450–6. DOI: 10.1007/s00381-002-0608-x

10. Konovalov A.N., Kadyrov Sh.U. Surgical approaches to thalamic tumors. Zhurnal Voprosy khirurgii im. N.N. Burdenko = Burdenko’s Journal of Neurosurgery 2011;75(1):4–11. (In Russ.).

11. Steiger H.J., Götz C., Schmid-Elsaesser R., Stummer W. Thalamic astrocytomas: surgical anatomy and results of a pilot series using maximum microsurgical removal. Acta Neurochir (Wien) 2000;142(12):1327–36; discussion 1336–7. DOI: 10.1007/s007010070001

12. Saito R., Kumabe T., Kanamori M. et al. Distant recurrences limit the survival of patients with thalamic high-grade gliomas after successful resection. Neurosurg Rev 2017;40(3):469–77. DOI: 10.1007/s10143-016-0804-x

13. Almubarak A., Alobaid A., Qoqandi O., Bafaquh M. Minimally invasive brain port approach for accessing deep-seated lesions using simple syringe. World Neurosurg 2018;117:54–61. DOI: 10.1016/j.wneu.2018.05.236

14. Marenco-Hillembrand L., Prevatt C., Suarez-Meade P. et al. Minimally invasive surgical outcomes for deep-seated brain lesions treated with different tubular retraction systems : a systematic review and meta-analysis. World Neurosurg 2020;143:537–45.e3. DOI: 10.1016/j.wneu.2020.07.115

15. Trashkov A.P., Spitin A.L., Tsygan N.V. et al. Cerebral glial tumors: general principles of diagnostics and treatment. Pediatr = Pediatrician (St Petersburg) 2015;6(4):75–84. (In Russ.). DOI: 10.17816/PED6475-84

16. Ulitin A.Yu. Epidemiology of primary brain tumors among the population of a large city and ways to improve the organization of medical care for patients with this pathology. Abstract of dis. ... candidate of medical sciences. St. Petersburg, 1997. 19 p. (In Russ.).

17. Banov S.M., Golanov A.V., Dolgushin M.B. et al. Brain metastases: current clinical recommendations. Onkologicheskiy zhurnal: luchevaya diagnostika, luchevaya terapiya = Journal of Oncology: Diagnostic Radiology and Radiotherapy 2018;1(3):75–84. (In Russ.). DOI: 10.37174/2587-7593-2018-1-3-75-84

18. Hajtovic S., Sun J., Multani J.S. et al. Surgical cytoreduction of deep-seated high-grade glioma through tubular retractor. J Neurosurg 2022;139(1):73–84. DOI: 10.3171/2022.9.JNS22842

19. Belyaev A.Yu. Astrocytomas and oligodendrogliomas of grade 3 malignancy in adults: clinic, diagnosis, treatment. Abstract of dis. ... doctor of medical sciences. Moscow, 2023. 47 p. (In Russ.).

20. Karschnia P., Vogelbaum M.A., van den Bent M. et al. Evidence-based recommendations on categories for extent of resection in diffuse glioma. Eur J Cancer 2021;149:23–33. DOI: 10.1016/j.ejca.2021.03.002

21. Esquenazi Y., Moussazadeh N., Link T.W. et al. Thalamic glioblastoma: clinical presentation, management strategies, and outcomes. Clin Neurosurg 2018;83(1):76–85. DOI: 10.1093/neuros/nyx349

22. Chang S.M., Parney I.F., McDermott M. et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 2003;98(6):1175–81. DOI: 10.3171/jns.2003.98.6.1175

23. Groshev A., Padalia D., Patel S. et al. Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomy. Clin Neurol Neurosurg 2017;157:25–30. DOI: 10.1016/j.clineuro.2017.03.017